With so much money and attention focused on the cannabis space over the past month, it will be increasingly incumbent upon companies like Aphria Inc (OTCMKTS:APHQF) to find new strategies to stand out to investors as well as to get around a coming tightening in pure production margins given the jump in supply that must come from such a massive flood of new capacity. The company’s latest move is an interesting step in that direction.
Specifically, the company just announced today that they have signed a non-binding Memorandum of Understanding related to RDT’s QuickStrip products. According to the release, “Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip products for cannabis markets around the world.”
Aphria Inc (OTCMKTS:APHQF) bills itself as a company that produces, supplies, and sells medical cannabis in Canada. Its cannabis products include dried flowers and cannabis oils. APHQF sells its products through its online store and telephone orders, as well as MMPR licensed producers.
The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
According to press materials, “APHQF is one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. APHQF is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”
Find out when $APHQF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, APHQF shares have been ripping higher as the company moves back into a clear leadership position in the Canadian cannabis patch, further helped by its latest move to enter the QuickStrip market (an easy-to-use, safe and effective oral fast-dissolving drug delivery system).
Shares continue to exhibit sharp strength, ramping 95% higher during the past month. In addition, the company has benefitted from a jump in recent trading volume to the tune of just shy of 250% above the average volume levels in play in this stock over the longer term.
“Aphria is committed to bringing breakthrough innovations to the global cannabis market, which is why we are excited to introduce RDT as a strategic innovation partner,” said Jakob Ripshtein, Chief Commercial Officer at Aphria. “They have developed a truly innovative product that will offer both patients and consumers a new way to consume and experience cannabis. We eagerly anticipate launching QuickStrip™ delivery technology across our portfolio of medical and adult-use brands and look forward to extending this valuable partnership to other markets around the world.”
At this time, carrying a capital value in the market of $3.63B, APHQF has a significant war chest ($59.7M) of cash on the books, which is balanced by about $43.9M in total current liabilities. APHQF is pulling in trailing 12-month revenues of $36.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 110.3%. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $APHQF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $APHQF, either long or short, and we have not been compensated for this article.